Pattern Recognition Molecules of the Lectin Pathway-Screening of Patients with Suspected Immunodeficiency

J Clin Immunol. 2019 Oct;39(7):668-677. doi: 10.1007/s10875-019-00675-8. Epub 2019 Aug 3.

Abstract

Purpose: To compare plasma concentrations of all lectin pathway (LP) pattern recognition molecules (PRMs) in patients referred for laboratory evaluation due to recurrent infections with healthy individuals.

Methods: Patients were divided into categories according to referral: recurrent airway infections (RAI), recurrent abscesses, common variable immunodeficiency (CVID), lung transplantation candidates (LTX), and 'other causes'. LP PRMs (mannose-binding lectin (MBL), collectin liver 1 (CL-L1), H-ficolin, L-ficolin, M-ficolin) and C-reactive protein (CRP) were determined in 332 patients and 150 healthy blood donors using time-resolved immunofluorometric assays.

Results: None of the LP PRMs was found in lower concentration in the patient categories; however, several PRMs were detected in higher concentrations. M-ficolin was found in higher concentrations in all patient categories. Patients suffering from RAI had higher concentrations of CL-L1 and H-ficolin. Patients suffering from abscesses exhibited higher concentrations of MBL and CL-L1, whereas LTX had higher concentrations of MBL. Patients with other causes of referral had higher concentrations of MBL and CL-L1. Prevalence of combined deficiencies of PRMs in patient categories and controls did not differ. CRP was used as a marker of ongoing inflammation and was significantly higher among all patient categories. Furthermore, CRP was found to correlate with both M-ficolin and L-ficolin.

Conclusion: The results suggest that neither single nor combined deficiencies of LP PRMs are more frequent among patients referred for an immunological evaluation than in healthy individuals. Future studies are needed and should focus on deficiencies of LP PRMs combined with deficiencies in other parts of the immune system.

Keywords: Complement; Immunodeficiency; Immunological evaluation; Lectin pathway; Screening.

MeSH terms

  • Biomarkers*
  • C-Reactive Protein
  • Denmark / epidemiology
  • Disease Susceptibility
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunologic Deficiency Syndromes / blood*
  • Immunologic Deficiency Syndromes / diagnosis*
  • Immunologic Deficiency Syndromes / etiology
  • Immunologic Deficiency Syndromes / metabolism
  • Lectins / blood*
  • Male
  • Mass Screening
  • Signal Transduction

Substances

  • Biomarkers
  • Lectins
  • C-Reactive Protein